Some recent and upcoming conferences with presentations from Pandeylab members
Targeting androgen production by post-translational regulation of CYP17A1 lyase activity.
Mutation V631I in the Cytochrome P450 oxidoreductase (POR) alters steroid biosynthesis and drug metabolism.
PDE5 inhibitors may reverse the effects of isolated growth hormone deficiency caused by alternate splicing of the GH1 gene.
Inhibiting the binding of ACTH to the Melanocorticotropin receptor by peptide to block androgen production.
At 2023 at 15th International Symposium on Cytochrome P450 - Biodiversity and Biotechnology, 27 to 30 June 2023
At ASPET 2023 Annual Meeting, St Louis, MO USA
18th to 21st May 2023
AT ASPET 2023 Annual Meeting, St. Louis, MO, USA
18th to 21st May 2023
At ASPET 2023, St Louis MO USA,
On binding of ACTH to MC2R for treatment of Congenital Adrenal Hyperplasia
At LS2 Annual Meeting, Zurich Switzerland. 15th to 17th February 2023
Grants
Regulation of Metabolism Conformational Changes in an Electron Transport Protein
Inhibitors of androgen biosynthesis for the treatment of castration-resistant prostate cancer.
Role of CYP6Z1 in metabolism of insecticides and development of insecticide resistance in mosquitoes.
Role of POR mutations in human metabolism
Generation of personalized models of mutations in POR deficiency.
Role of POR in metabolic Regulation and protein stability.
Regulation of androgen biosynthesis in PCOS and prostate cancer.
Swiss Government Excellence Scholarship. 2019-2022
Swiss Government Excellence Scholarship. 2020-2023
Swiss Government Excellence Scholarship. 2022-2025
Swiss Government Excellence Scholarship. 2023-2026
Swiss Government Excellence Scholarship. 2023-2026
Swiss Government Excellence Scholarship. 2020-2021
Swiss Government Excellence Scholarship. 2020-2021
Best Poster Award for PhD students at DBMR Annual Research Conference 2022